SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF THE ADJUVANTED TRIVALENT SUBUNIT INFLUENZA VACCINE AND THE NON-ADJUVANTED TRIVALENT SUBUNIT INFLUENZA VACCINE COMPARED TO THE NON-ADJUVANTED TRIVALENT SPLIT INFLUENZA VACCINE IN CHILDREN 6 TO < 72 MONTHS OF AGE: